Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Third party research

Ossdsign: Cash injection supports growth - ABG

OssDsign

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
50% y-o-y organic sales growth in Q2'25e
EBIT forecasts raised by 1.0-55.7% for '25e-'27e
Q2'25 results due 19 August


Q2'25 expectations

We expect the positive sales momentum to have continued for OssDsign in Q2, driven by continued improved market access by adding new hospitals and deeper penetration among existing hospitals by broadening the base of surgeons using Catalyst. All in all, we forecast Q2 sales of SEK 41.8m, equal to organic growth of 50% y-o-y, and EBIT of SEK -8.6m on fairly flattish opex assumptions compared with Q1'25. Given its 100% sales exposure to the US and the USD, we estimate the FX headwind to have been 10% for Q2, holding back reported sales growth but also helping to keep the opex level relatively flattish compared with Q1'25 given the high cost base in USD. For Q2, we forecast a gross margin of 95.0%, down from 96.4% in Q1'25, partly due to the US tariffs.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.